tiprankstipranks
Zevra Therapeutics (ZVRA)
NASDAQ:ZVRA
US Market

Zevra Therapeutics (ZVRA) Income Statement

Compare
871 Followers

Zevra Therapeutics Income Statement

Last quarter (Q3 2024), Zevra Therapeutics's total revenue was $3.69M, an increase of 27.63% from the same quarter last year. In Q3, Zevra Therapeutics's net income was $-33.23M. See Zevra Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 27.46M$ 10.46M$ 28.65M$ 13.29M$ 12.84M
Gross Profit
$ 24.52M$ 10.12M$ 26.59M$ 11.98M$ 9.89M
Operating Expenses
$ 74.12M$ 34.96M$ 18.86M$ 16.76M$ 30.23M
Depreciation and Amortization
$ 1.01M$ 944.00K$ 257.00K$ 273.00K$ 304.00K
EBITDA
$ -48.60M$ -25.53M$ -7.89M$ -5.43M$ -17.73M
Operating Income
$ -49.60M$ -24.84M$ 7.73M$ -4.78M$ -20.34M
Other Income/Expenses
$ 3.56M$ -1.96M$ -16.25M$ -7.18M$ -4.21M
Pretax Income
$ -46.05M$ -42.33M$ -8.52M$ -12.79M$ -24.54M
Net Income
$ -46.05M$ -41.54M$ -8.55M$ -12.76M$ -24.52M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.30$ -1.20$ -0.29$ -3.21$ -13.23
Diluted EPS
$ -1.30$ -1.20$ -0.29$ -3.21$ -13.23
Weighted Average Shares Outstanding
35.45M 34.49M 29.77M 3.98M 1.85M
Weighted Average Shares Outstanding (Diluted)
35.45M 34.49M 29.77M 3.98M 1.85M
Currency in USD

Zevra Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis